P-1055

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameP-1055
Drug Alias NameP-1055
ClassificationSmall molecules
Mechanisms of ActionEpithelial sodium channel blockers
TargetsEpithelial sodium channel
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic ObstructiveCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesParion Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesVertex Pharmaceuticals IncorporatedParion Sciences Inc
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic ObstructiveCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A